학술논문
Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis
Document Type
Article
Author
Source
In: Pharmacoepidemiology and Drug Safety . (Pharmacoepidemiology and Drug Safety, June 2022, 31(6):670-679)
Subject
Language
English
ISSN
10991557
10538569
10538569